Neoadjuvant Chemoradiotherapy Enhances Tumor PD-L1 Expression in Pancreatic Cancer
NACRT in pancreatic cancer may affect TILs and PD-L1 expression, thereby improving the immunosuppressive microenvironment and implying a potential synergy between checkpoint inhibitors and radiation treatment.
Authors
- Yasuhiro Yabushita (ORCID: https://orcid.org/0000-0003-1090-1614)
- Kanechika Den
- Y. Homma (ORCID: https://orcid.org/0000-0002-9872-9697)
- Ryusei Matsuyama (ORCID: https://orcid.org/0000-0001-5131-0023)
- Rintaro Mori (ORCID: https://orcid.org/0000-0001-7656-6156)
- Itaru Endo (ORCID: https://orcid.org/0000-0001-5520-8114)
- Takashi Murakami (ORCID: https://orcid.org/0000-0002-9429-5705)
- Ikuma Kato (ORCID: https://orcid.org/0000-0002-7731-9509)
- Kentaro Miyake (ORCID: https://orcid.org/0000-0002-4680-4317)
- Yukihiko Hiroshima (ORCID: https://orcid.org/0009-0005-7384-3513)
Institutions
- Yokohama City University (JP)
Publication Details
- Journal
- Anticancer Research
- Published
- 2025-03-28
- DOI
- https://doi.org/10.21873/anticanres.17554
- Citations
- 1
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 1.05